Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes

Experimental Cell Research

Volumn 283, Issue 1, 2003, Pages 17-21

  Gartel, Andrei L ^a   Shchors, Ksenya ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 4; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MYC PROTEIN; PROTEIN; PROTEIN GADD34; PROTEIN GAS1; PROTEIN MIZ 1; PROTEIN P15; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE; DNA BINDING; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTO ONCOGENE; SHORT SURVEY; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0037330625     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00020-4     Document Type: Short Survey

References (37)

1. Henriksson M., Luscher B. Proteins of the Myc network Essential regulators of cell growth and differentiation . Adv. Cancer Res. 68:1996;109-182.
2. Dang C.V., Resar L.M., Emison E., Kim S., Li Q., Prescott J.E., Wonsey D., Zeller K. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253:1999;63-77.
3. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene. 18:1999;3004-3016.
4. Liao D.J., Dickson R.B. c-Myc in breast cancer. Endocr. Relat. Cancer. 7:2000;143-164.
5. Oster S.K., Ho C.S., Soucie E.L., Penn L.Z. The myc oncogene Marvelously complex . Adv. Cancer Res. 84:2002;81-154.
6. Murre C., Bain G., van Dijk M.A., Engel I., Furnari B.A., Massari M.E., Matthews J.R., Quong M.W., Rivera R.R., Stuiver M.H. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta. 1218:1994;129-135.
7. Baudino T.A., Cleveland J.L. The Max network gone mad. Mol. Cell. Biol. 21:2001;691-702.
8. Claassen G.F., Hann S.R. Myc-mediated transformation The repression connection . Oncogene. 18:1999;2925-2933.
9. Xiao Q., Claassen G., Shi J., Adachi S., Sedivy J., Hann S.R. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12:1998;3803-3808.
10. Polyak K. Negative regulation of cell growth by TGF beta. Biochim. Biophys. Acta. 1242:1996;185-199.
11. Akhurst R.J., Derynck R. TGF-beta signaling in cancer - A double-edged sword. Trends Cell Biol. 11:2001;S44-S51.
12. Alexandrow M.G., Kawabata M., Aakre M., Moses H.L. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc. Natl. Acad. Sci. USA. 92:1995;3239-3243.
13. Hui A.M., Sun L., Kanai Y., Sakamoto M., Hirohashi S. Reduced p27Kip1 expression in hepatocellular carcinomas. Cancer Lett. 132:1998;67-73.
14. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
15. Li J.-M., Datto M., Shen X., Hu P., Yu Y., Wang X.-F. Sp1, but not Sp3 functions to mediate promoter activation by TGF-b through canonical Sp1 binding sites. Nucleic Acids Res. 26:1998;2449-2456.
16. Claassen G.F., Hann S.R. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA. 97:2000;9498-9503.
17. Feng X.H., Lin X., Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 19:2000;5178-5193.
18. Seoane J., Pouponnot C., Staller P., Schader M., Eilers M., Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3:2001;400-408.
19. Mitchell K.O., El-Deiry W.S. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S- phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10:1999;223-230.
20. Gartel A.L., Ye X., Goufman E., Shianov P., Hay N., Najmabadi F., Tyner A.L. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. USA. 98:2001;4510-4515.
21. Staller P., Peukert K., Kiermaier A., Seoane J., Lukas J., Karsunky H., Moroy T., Bartek J., Massague J., Hanel F., Eilers M. Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell. Biol. 3:2001;392-399.
22. Yang W., Shen J., Wu M., Arsura M., FitzGerald M., Suldan Z., Kim D.W., Hofmann C.S., Pianetti S., Romieu-Mourez R., Freedman L.P., Sonenshein G.E. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene. 20:2001;1688-1702.
23. Feng X.H., Liang Y.Y., Liang M., Zhai W., Lin X. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta mediated induction of the CDK inhibitor p15(Ink4B). Mol. Cell. 9:2002;133-143.
24. Reynisdottir I., Massague J. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:1997;492-503.
25. Warner B.J., Blain S.W., Seoane J., Massague J. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol. 19:1999;5913-5922.
26. Roy A.L., Carruthers C., Gutjahr T., Roeder R.G. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature. 365:1993;359-361.
27. Shrivastava A., Saleque S., Kalpana G.V., Artandi S., Goff S.P., Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science. 262:1993;1889-1892.
28. Peukert K., Staller P., Schneider A., Carmichael G., Hanel F., Eilers M. An alternative pathway for gene regulation by Myc. EMBO J. 16:1997;5672-5686.
29. Coller H.A., Grandori C., Tamayo P., Colbert T., Lander E.S., Eisenman R.N., Golub T.R. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA. 97:2000;3260-3265.
30. Arsura M., Deshpande A., Hann S.R., Sonenshein G.E. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation. Mol. Cell. Biol. 15:1995;6702-6709.
31. Mateyak M.K., Obaya A.J., Sedivy J.M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19:1999;4672-4683.
32. Lee T.C., Li L., Philipson L., Ziff E.B. Myc represses transcription of the growth arrest gene gas1. Proc. Natl. Acad. Sci. USA. 94:1997;12886-12891.
33. Chen C., Nussenzweig A., Guo M., Kim D., Li G.C., Ling C.C. Down-regulation of gadd153 by c-myc in rat fibroblasts and its effect on cell growth and radiation-induced apoptosis. Oncogene. 13:1996;1659-1665.
34. Marhin W.W., Chen S., Facchini L.M., Fornace A. Jr., Penn L.Z. Myc represses the growth arrest gene gadd45. Oncogene. 14:1997;2825-2834.
35. Amundson S.A., Zhan Q., Penn L.Z., Fornace A. Jr. Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents. Oncogene. 17:1998;2149-2154.
36. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
37. Bush A., Mateyak M., Dugan K., Obaya A., Adachi S., Sedivy J., Cole M. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev. 12:1998;3797-3802.